UroGen Pharma Ltd. appointed Stephen Mullennix as COO.
Mullennix previously served as the CFO and senior vice president of operations for SolarReserve LLC, a power company.
UroGen Pharma appoints COO
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
UroGen Pharma Ltd. appointed Stephen Mullennix as COO.
Mullennix previously served as the CFO and senior vice president of operations for SolarReserve LLC, a power company.